Stock Spotlight Archives - Page 121 of 383

ThursdayMar 17, 2022 2:44 pm

QualityStocksNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) CEO Discusses Significant Milestone in Advancing Berubicin

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, recently participated in the Virtual Investor 2022 Top Picks Conference. The company’s CEO John Climaco provided a corporate presentation and participated in a moderated questions and answer session during the event. Berubicin, a novel anthracycline and the first in its drug class to appear to cross the blood-brain barrier, is CNS Pharmaceuticals’ lead drug candidate. “The company is currently developing treatments using Berubicin for serious brain and central nervous system oncology indications, including glioblastoma…

WednesdayMar 16, 2022 2:25 pm

QualityStocksNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Launching Additional Rare Cannabinoids in Response to Inbound Demand

InMed Pharmaceuticals (NASDAQ: INM), a clinical-stage company developing cannabinoid-based pharmaceutical drug candidates and manufacturing technologies for pharmaceutical-grade rare cannabinoids, has dedicated itself to developing new therapeutic alternatives for the treatment of conditions with high unmet medical needs. The manufacturing process used by InMed and its recently acquired subsidiary BayMedica is unparalleled in the industry. “There is no ‘one-size-fits-all’ approach to cannabinoid manufacturing, so multiple avenues are required to realize the maximum outcome for the targeted cannabinoid. InMed and BayMedica, like a well-oiled machine, work together using biosynthesis, chemical synthesis and the proprietary IntegraSyn(TM) manufacturing models,” a recent article explains. “Together,…

WednesdayMar 16, 2022 2:04 pm

QualityStocksNewsBreaks – Laredo Oil Inc. (LRDC) Looking to Contribute to Projected Increase in US Oil Production

Laredo Oil (OTC: LRDC) is in a strong position to benefit from the forecasted growth in domestic crude oil production. The U.S. Energy Information Agency (“EIA”), in its February 2022 Short-Term Energy Outlook (“STEO”), projected that crude oil prices will remain high enough to drive U.S. crude oil production to record-high levels in 2023, reaching a forecast 12.6 million barrels per day (“b/d”), up 760,000 b/d from 2021. “Laredo is looking to contribute to increased oil production. The company’s strategy involves a focus on unlocking value when others have overlooked it, emphasizing free cash flow that allows the company to…

TuesdayMar 15, 2022 3:45 pm

QualityStocksNewsBreaks – SPYR Inc. (SPYR) Subsidiary Names New Advisory Board Member

SPYR (OTCQB: SPYR), dba SPYR Technologies, a technology company and its subsidiary, Applied Magix Inc., have appointed a new advisory board member. Fred Tio, a former senior creative director of Worldwide Marcom, Apple Inc., has accepted an invitation to serve on the Applied Magix advisory board. Applied Magix develops and resells Apple(R) ecosystem-compatible products in the growing multibillion-dollar IoT smart home and connected car markets. According to the announcement, Tio is looking forward to bringing his Apple experience and passion to the Applied Magix line of products. The company noted that Tio’s influence will be felt on the development and expansion of…

TuesdayMar 15, 2022 3:36 pm

QualityStocksNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Commencement of DehydraTECH-CBD Epilepsy Research Program

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced that the first phase of its epilepsy research program EPIL-A21-1 is beginning this week. According to the update, the DehydraTECH(TM)-CBD test articles needed to commence dosing have already been manufactured and delivered to the third-party laboratory engaged to complete this research program. EPIL-A21-1 will assess the seizure inhibiting activity of DehydraTECH-CBD compared to the world's only FDA-approved CBD-based seizure medication, Epidiolex(R). Lexaria hopes to demonstrate superior performance based on DehydraTECH’s known advanced drug delivery capabilities. Lexaria's seizure program expects to leverage the significant gains in systemic…

TuesdayMar 15, 2022 2:35 pm

QualityStocksNewsBreaks – FuelPositive Corporation (TSX.V: NHHH) (OTCQB: NHHHF) Moving Forward at Full Speed to Commercialize Green Ammonia Production System

FuelPositive (TSX.V: NHHH) (OTCQB: NHHHF) recently announced that it is on track to deliver the first prototype of its modular green ammonia production system in late summer 2022. According to company Chief Operating Officer Nelson Leite, “FuelPositive is moving forward at full speed to commercialize our in situ, modular, scalable, and transportable green ammonia production system.” Per the announcement, the building of the first demonstration units for its green ammonia production system is progressing according to plan. The system is made up of a nitrogen generator to extract nitrogen from the air, a water electrolyzer to generate hydrogen from water,…

TuesdayMar 15, 2022 2:25 pm

QualityStocksNewsBreaks – Eat Well Investment Group Inc. (CSE: EWG) (OTC: EWGFF) Solving Critical Gap in Chain of Plant-Based Foods

Eat Well Investment Group (CSE: EWG) (OTC: EWGFF), a vertically integrated plant-based foods company, continues to build on acquisitions to solidify its position as a producer of nutritious foods with end-to-end supply chain linkage. A recent article discussing company CEO, President and Director Marc Aneed’s interview with The Bell2Bell Podcast quotes him as saying, “We’re one of the forerunners, we would say, today in solving the critical gap in the chain of plant-based foods… With a collection of astute, strategic investments … we’ve created a vertically integrated model whereby we have plant-based proteins that we process close to the farm…

MondayMar 14, 2022 3:42 pm

QualityStocksNewsBreaks – Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) Taping ‘Truly Immense Opportunity’ Amid Rising Demand for Rare Earths

Energy Fuels (NYSE American: UUUU) (TSX: EFR) is emerging to become one of the diverse suppliers of rare earth elements (“REEs”). The company has seen monumental progress in its efforts to enter the REE market, which is expected to experience healthy growth. And, if demand continues to grow at its current pace, supply will need to pick up to meet the need for REEs globally. Analyst Ryan Castilloux, managing director of Adamas Intelligence, indicates that, while China will almost certainly remain a key player in the space, the next two to three years will be transitional for the supply chain…

MondayMar 14, 2022 3:29 pm

QualityStocksNewsBreaks – InnerScope Hearing Technologies Inc. (INND) Working to Achieve Most Attractive Financial Terms to Support Growth, Maximize Shareholder Value

InnerScope Hearing Technologies (OTC: INND), an emerging and disruptive leader in the direct-to-consumer (“DTC”) hearing technology space, recently renegotiated financing agreements with GS Capital Partners LLC, the holder of its securities, canceling a series of variable price convertible notes. “As a result of the restructuring transactions, the total principal amounting to $1.1 million held by GS Capital Partners has been eliminated, equivalent to almost half of the company’s outstanding variable price convertible notes. InnerScope expects to eliminate the remainder of its current variable price convertible notes in several weeks in a bid to enhance its balance sheet toward a shareholder-friendly…

FridayMar 11, 2022 3:10 pm

QualityStocksNewsBreaks – Nemaura Medical Inc.’s (NASDAQ: NMRD) Revolutionary sugarBEAT(R) CGM Device Met with Early Success

Nemaura Medical (NASDAQ: NMRD), a medical technology company, has sought to develop and offer economical, compact and convenient non-invasive devices that could alleviate the pain associated with frequent skin pricking among diabetic patients. The devices also simultaneously promote routine glucose testing in a bid to control blood glucose levels more effectively. Nemaura offers two flagship constant glucose monitoring (“CGM”) products: the sugarBEAT(R), a non-invasive wearable diagnostic device, and MiBoKo, an application that supports personalized lifestyle coaching programs. A recent article reads: “The company’s revolutionary sugarBEAT(R) CGM device seeks to provide users with non-invasive glucose monitoring; as described by the company,…

Site Search

Company Search

Category: Stock Spotlight